Sex steroids and bone mass. A study of changes about the time of menopause (original) (raw)

Abstract

To examine the relationships between bone loss and sex steroids, 84 peri- and postmenopausal women were studied at 4-mo intervals for 3 yr. At each visit, measurements were made of bone mass at the midshaft and distal radius, of steroids, of gonadotropins, and of bone gla protein (BGP). Bone loss was approximately 1% per yr among late perimenopausal and postmenopausal groups, whereas the early perimenopausal group lost no bone. Mean serum estrogen and BGP concentrations predicted rates of bone loss. BGP was negatively correlated with the rate of bone loss (r = -0.45) and with mean estrogen concentrations (r = -0.40). Multivariate regressions showed estrogen concentrations to be strong independent predictors of the slope of bone mass over time. When BGP concentrations were added to the models, the significance of estrogen was reduced, suggesting that a portion of the estrogen effect was mediated through effects on rates of bone remodelling.

1261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken J. M., Hart D. M., Smith D. A. The effect of long-term mestranol administration on calcium and phosphorus homeostasis in oophorectomized women. Clin Sci. 1971 Sep;41(3):233–236. doi: 10.1042/cs0410233. [DOI] [PubMed] [Google Scholar]
  2. Baird D. T., Horton R., Longcope C., Tait J. F. Steroid dynamics under steady-state conditions. Recent Prog Horm Res. 1969;25:611–664. doi: 10.1016/b978-0-12-571125-8.50017-x. [DOI] [PubMed] [Google Scholar]
  3. Baird D., Horton R., Longcope C., Tait J. F. Steroid prehormones. Perspect Biol Med. 1968 Spring;11(3):384–421. doi: 10.1353/pbm.1968.0053. [DOI] [PubMed] [Google Scholar]
  4. Cameron J. R., Mazess R. B., Sorenson J. A. Precision and accuracy of bone mineral determination by direct photon absorptiometry. Invest Radiol. 1968 May-Jun;3(3):141–150. doi: 10.1097/00004424-196805000-00001. [DOI] [PubMed] [Google Scholar]
  5. Christiansen C., Christensen M. S., McNair P., Hagen C., Stocklund K. E., Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest. 1980 Aug;10(4):273–279. doi: 10.1111/j.1365-2362.1980.tb00033.x. [DOI] [PubMed] [Google Scholar]
  6. Davidson B. J., Riggs B. L., Wahner H. W., Judd H. L. Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures. Obstet Gynecol. 1983 Mar;61(3):275–278. [PubMed] [Google Scholar]
  7. Deftos L. J., Weisman M. H., Williams G. W., Karpf D. B., Frumar A. M., Davidson B. J., Parthemore J. G., Judd H. L. Influence of age and sex on plasma calcitonin in human beings. N Engl J Med. 1980 Jun 12;302(24):1351–1353. doi: 10.1056/NEJM198006123022407. [DOI] [PubMed] [Google Scholar]
  8. Delmas P. D., Stenner D., Wahner H. W., Mann K. G., Riggs B. L. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest. 1983 May;71(5):1316–1321. doi: 10.1172/JCI110882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dequeker J., Geusens P. Contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 1985 Aug 15;313(7):453–453. doi: 10.1056/NEJM198508153130716. [DOI] [PubMed] [Google Scholar]
  10. Epstein S., Poser J., McClintock R., Johnston C. C., Jr, Bryce G., Hui S. Differences in serum bone GLA protein with age and sex. Lancet. 1984 Feb 11;1(8372):307–310. doi: 10.1016/s0140-6736(84)90360-x. [DOI] [PubMed] [Google Scholar]
  11. Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
  12. Gallagher J. C., Riggs B. L., DeLuca H. F. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1980 Dec;51(6):1359–1364. doi: 10.1210/jcem-51-6-1359. [DOI] [PubMed] [Google Scholar]
  13. Gallagher J. C., Young M. M., Nordin B. E. Effects of artificial menopause on plasma and urine calcium and phosphate. Clin Endocrinol (Oxf) 1972 Jan;1(1):57–64. doi: 10.1111/j.1365-2265.1972.tb00377.x. [DOI] [PubMed] [Google Scholar]
  14. Genant H. K., Cann C. E., Ettinger B., Gordan G. S. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982 Nov;97(5):699–705. doi: 10.7326/0003-4819-97-5-699. [DOI] [PubMed] [Google Scholar]
  15. Gotfredsen A., Nilas L., Riis B. J., Thomsen K., Christiansen C. Bone changes occurring spontaneously and caused by estrogen in early postmenopausal women: a local or generalised phenomenon? Br Med J (Clin Res Ed) 1986 Apr 26;292(6528):1098–1100. doi: 10.1136/bmj.292.6528.1098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Heaney R. P. A unified concept of osteoporosis. Am J Med. 1965 Dec;39(6):877–880. doi: 10.1016/0002-9343(65)90109-9. [DOI] [PubMed] [Google Scholar]
  17. Heaney R. P., Recker R. R. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Med. 1982 Jan;99(1):46–55. [PubMed] [Google Scholar]
  18. Heaney R. P., Recker R. R., Saville P. D. Menopausal changes in bone remodeling. J Lab Clin Med. 1978 Dec;92(6):964–970. [PubMed] [Google Scholar]
  19. Horsman A., Simpson M., Kirby P. A., Nordin B. E. Non-linear bone loss in oophorectomized women. Br J Radiol. 1977 Jul;50(595):504–507. doi: 10.1259/0007-1285-50-595-504. [DOI] [PubMed] [Google Scholar]
  20. Lindsay R., Hart D. M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet. 1980 Nov 29;2(8205):1151–1154. doi: 10.1016/s0140-6736(80)92592-1. [DOI] [PubMed] [Google Scholar]
  21. Longcope C., Baker R. S., Hui S. L., Johnston C. C., Jr Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas. 1984 Dec;6(4):309–318. doi: 10.1016/0378-5122(84)90002-1. [DOI] [PubMed] [Google Scholar]
  22. Longcope C., Kato T., Horton R. Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest. 1969 Dec;48(12):2191–2201. doi: 10.1172/JCI106185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Longcope C. Methods and results of aromatization studies in vivo. Cancer Res. 1982 Aug;42(8 Suppl):3307s–3311s. [PubMed] [Google Scholar]
  24. Longcope C., Pratt J. H., Schneider S. H., Fineberg S. E. Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab. 1978 Jan;46(1):146–152. doi: 10.1210/jcem-46-1-146. [DOI] [PubMed] [Google Scholar]
  25. Longcope C., Watson D., Williams K. I. The effects of synthetic estrogens on the metabolic clearance and production rates of estrone and estradiol. Steroids. 1974 Jul;24(1):15–30. doi: 10.1016/0039-128x(74)90042-7. [DOI] [PubMed] [Google Scholar]
  26. Marshall D. H., Crilly R. G., Nordin B. E. Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women. Br Med J. 1977 Nov 5;2(6096):1177–1179. doi: 10.1136/bmj.2.6096.1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pratt J. H., Longcope C. Effect of adrenocorticotropin on production rates and metabolic clearance rates of testosterone and estradiol. J Clin Endocrinol Metab. 1978 Aug;47(2):307–313. doi: 10.1210/jcem-47-2-307. [DOI] [PubMed] [Google Scholar]
  28. Riggs B. L., Melton L. J., 3rd Involutional osteoporosis. N Engl J Med. 1986 Jun 26;314(26):1676–1686. doi: 10.1056/NEJM198606263142605. [DOI] [PubMed] [Google Scholar]
  29. Riggs B. L., Ryan R. J., Wahner H. W., Jiang N. S., Mattox V. R. Serum concentrations of estrogen, testosterone, and gonadotropins in osteoporotic and nonosteoporotic postmenopausal women. J Clin Endocrinol Metab. 1973 Jun;36(6):1097–1099. doi: 10.1210/jcem-36-6-1097. [DOI] [PubMed] [Google Scholar]
  30. Riggs B. L., Wahner H. W., Dunn W. L., Mazess R. B., Offord K. P., Melton L. J., 3rd Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981 Feb;67(2):328–335. doi: 10.1172/JCI110039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Riggs B. L., Wahner H. W., Melton L. J., 3rd, Richelson L. S., Judd H. L., Offord K. P. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest. 1986 May;77(5):1487–1491. doi: 10.1172/JCI112462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schlenker R. A., VonSeggen W. W. The distribution of cortical and trabecular bone mass along the lengths of the radius and ulna and the implications for in vivo bone mass measurements. Calcif Tissue Res. 1976 Apr 13;20(1):41–52. doi: 10.1007/BF02546396. [DOI] [PubMed] [Google Scholar]
  33. Selby P. L., Peacock M., Barkworth S. A., Brown W. B., Taylor G. A. Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones. Clin Sci (Lond) 1985 Sep;69(3):265–271. doi: 10.1042/cs0690265. [DOI] [PubMed] [Google Scholar]
  34. Stevenson J. C., Abeyasekera G., Hillyard C. J., Phang K. G., MacIntyre I., Campbell S., Townsend P. T., Young O., Whitehead M. I. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet. 1981 Mar 28;1(8222):693–695. doi: 10.1016/s0140-6736(81)91973-5. [DOI] [PubMed] [Google Scholar]
  35. Verheugen C., Pardridge W. M., Judd H. L., Chaudhuri G. Differential permeability of uterine and liver vascular beds to estrogens and estrogen conjugates. J Clin Endocrinol Metab. 1984 Dec;59(6):1128–1132. doi: 10.1210/jcem-59-6-1128. [DOI] [PubMed] [Google Scholar]